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Summary
We performed a one year study to assess the impact of
CMR imaging on the management of patients with sus-
pected or confirmed cardiomyopathy.
Background
Investigation and risk stratification of suspected or con-
firmed cardiomyopathy traditionally involves correlation
between electrocardiographic, echocardiographic and
angiographic findings in an appropriate clinical setting.
C a r d i a cM a g n e t i cR e s o n a n c e( C M R )i st h en e wg o l d
standard in assessment of cardiac structure, function
and perfusion, provided in a single study. Aetiology and
prognostic factors may be investigated concurrently.
Methods
This was a single centre, 12-month experience of
patients referred for assessment of presumptive cardio-
myopathy. Images were provided by a 1.5T GE Scanner
and were reported by a Level 3 Reporter.
Results
224 patients (145 male, 79 female) underwent CMR
assessment of cardiomyopathy. 177 (79%) were outpati-
ent referrals.
The primary indications for CMR included
49 (21.9%) - Arrhythmia
42 (18.8%) - Abnormal echocardiogram with no cause
found
35 (15.6%) - Cardiac symptoms with normal
coronaries
32 (14.3%) - Screening for family history of CM/SCD
23 (10.3%) - Abnormal ECG/holter/stress test
18 (8%) - Follow-up of previously diagnosed CM
17 (7.6%) - Systemic illness
7 (3.1%) - ICD insertion
CMR provided sufficient information to confirm or
outrule cardiomyopathy in 68.2% of cases. A new diag-
nosis of cardiomyopathy was made in 25.4%. CMR also
had an important role in ongoing assessment of patients
with established diagnosis of cardiomyopathy, with
22.2% having their previous diagnosis outruled and
27.8% being recommended for device implantation as a
direct result of CMR findings.
Overall in cardiomyopathy assessment, CMR had an
impact on management in 50% of patients, with a thera-
peutic consequence on 36.2%, including medication
changes, angiography and device insertion.
Conclusions
Patients at all stages of the clinical spectrum of cardio-
myopathy, from initial presentation to institution of
therapy and long-term follow up may benefit from
CMR.
CMR should be implemented early in the diagnostis of
suspected cardiomyopathy. Our data demonstrates the
s i g n i f i c a n ti m p a c tC M Rc o n s istently has on confirming
diagnosis, guiding therapy and providing accurate prog-
nosis in this patient group.
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Table 1 Baseline Characteristics
Gender Male - 145 Female - 79
Referral Source OPD - 177 Inpatient - 47
BMI Mean - 26.7 kg/m2 StDev - 4.4 kg/m2
Age Mean - 63.4 years StDev - 16.7 years
Barrett and Waterhouse Journal of Cardiovascular Magnetic Resonance 2012, 14(Suppl 1):P146
http://www.jcmr-online.com/content/14/S1/P146
© 2012 Barrett and Waterhouse; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.Published: 1 February 2012
doi:10.1186/1532-429X-14-S1-P146
Cite this article as: Barrett and Waterhouse: The early role of CMR in the
assessment of cardiomyopathy. Journal of Cardiovascular Magnetic
Resonance 2012 14(Suppl 1):P146.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Figure 1
Barrett and Waterhouse Journal of Cardiovascular Magnetic Resonance 2012, 14(Suppl 1):P146
http://www.jcmr-online.com/content/14/S1/P146
Page 2 of 2